Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
NHS wins legal fight with pharma over off-label Avastin
Industry criticises judgement - fearful of 'undermining regulation' as well as big earning products
Gilead and ViiV among winners at PM Society Digital Awards
First 'Pharma Digital Partner' award presented
UK pharma to work with innovation network on NHS uptake
The five year deal covers AI, genomics, personalised medicine and more
Bayer roll-out of haemophilia drug Jivi gathers pace
Japan’s MHLW is next to approve the drug
Articles
-
The critical role of science in healthcare communicationsThe challenges and opportunities of driving the scientific agenda forward
-
Nurturing the growth mindset: The need for ongoing professional development in strategic medical communicationsWriting is a skill, a craft, an art
-
Cannes Lions Healthcare Agency of the Year – championing change and demanding more… The agency's role in unlocking the future of medicine, today.
-
The European Medicines Agency: PRIME’d for access? Leela Barham examines the impact of the EMA's PRIME fast track system after two years
-
Keytruda’s secret sauceMerck’s position in oncology is about much more than a good product
Pharmaceutical Market Europe - September 2018
We start off looking at the newly released 2018 edition of the Drugs to Watch Report, with 12 blockbusters predicted to launch this year. There is hope that some of these new drugs may help patients who are dealing with several of the most unmanageable diseases.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
The latest healthcare comms movers
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Nurturing the growth mindset: The need for ongoing professional development in strategic medical communications
Writing is a skill, a craft, an art
Featured jobs
-
Account Manager
-
Negotiable
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
-
Systematic Review Lead- London
-
Negotiable
- Account Director or Senior Account Director
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
-
Senior Medical Writer
-
Salary is DOE
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- AZ prepares to file COPD triple, taking on rival GSK
- J&J files ‘breakthrough’ bladder cancer drug in US
- Rival Opdivo rejected, Novartis combo gets NICE green light in adjuvant melanoma
- Teva wins FDA OK for crucial migraine drug
- NHS wins legal fight with pharma over off-label Avastin
- 3MZ Healthcare Communications: Improving Human Care
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
PMHub
Hanson Zandi
Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
